Giant Biogene Holding Co (HKSE:02367) Total Liabilities: HK$1,003 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02367 Giant Biogene Holding Co Ltd HKSE:02367
85 GF Score
Price HK$24.48
GF Value HK$68.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Giant Biogene Holding Co Total Liabilities?

Giant Biogene Holding Co HKSE:02367 +1.32% 85 Total Liabilities is HK$1,003 Mil as of Dec. 2025. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.03 (Possible Value Trap). The stock has 4 warning signs investors should review.

Giant Biogene Holding Co's Total Liabilities for the quarter that ended in Dec. 2025 was HK$1,003 Mil.

Giant Biogene Holding Co's quarterly Total Liabilities increased from Dec. 2024 (HK$956.94 Mil) to Jun. 2025 (HK$2,297.77 Mil) but then declined from Jun. 2025 (HK$2,297.77 Mil) to Dec. 2025 (HK$1,002.78 Mil).

Giant Biogene Holding Co's annual Total Liabilities increased from Dec. 2023 (HK$641.28 Mil) to Dec. 2024 (HK$956.94 Mil) and increased from Dec. 2024 (HK$956.94 Mil) to Dec. 2025 (HK$1,002.78 Mil).

Giant Biogene Holding Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Giant Biogene Holding Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giant Biogene Holding Co Total Liabilities Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 8,371.80 317.75 641.28 956.94 1,002.78

Giant Biogene Holding Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only 1,940.33 956.94 2,297.77 1,002.78 1,008.44
HKSE:02367
85GF Score
Giant Biogene Holding Co Ltd HKSE:02367
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giant Biogene Holding Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Giant Biogene Holding Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=891.01118235871+(0+3.3111291486421E-12
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++108.1402109285)
=999

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=12075.329796942-11054.366582143
=1,021

Giant Biogene Holding Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=891.01118235871+(0+3.3111291486421E-12
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++108.1402109285)
=999

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=12075.329796942-11054.366582143
=1,021

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$1,003 Mil mean?
Giant Biogene Holding Co (HKSE:02367) has a Total Liabilities of HK$1,003 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Giant Biogene Holding Co and its competitors.
Is Giant Biogene Holding Co's Total Liabilities too high?
Giant Biogene Holding Co's current Total Liabilities is HK$1,003 Mil. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Total Liabilities compare to PG and CL?
Giant Biogene Holding Co's Total Liabilities of HK$1,003 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Giant Biogene Holding Co and its competitors. Giant Biogene Holding Co's current Total Liabilities is HK$1,003 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.03, compared to a current price of HK$24.48 — trading 64% below its estimated fair value. The current Total Liabilities is HK$1,003 Mil. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Total Liabilities is HK$1,003 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?

Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued. The current stock price of HK$24.48 is trading 64% below its estimated GF Value™ of HK$68.03. GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.

Key valuation signals for HKSE:02367:

  • Total Liabilities: HK$1,003 Mil
  • GF Value™: HK$68.03 vs. price of HK$24.48 (64% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Giant Biogene Holding Co Business Description

Address No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score

Get the complete analysis for HKSE:02367

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$24.48
Price
HK$68.03
GF Value